药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02269 药明生物

已收盘 03-30 16:08:20

31.360

-1.000

-3.09%

最高32.480	最低30.940	成交量4,147万
今开32.000	昨收32.360	日振幅4.76%
总市值1,298亿	流通市值1,298亿	总股本41.38亿
成交额13.04亿	换手率1.00%	流通股本41.38亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02269","market":"HK","secType":"STK","nameCN":"药明生物","latestPrice":31.36,"timestamp":1774858100003,"preClose":32.36,"halted":0,"volume":41472932,"delay":0,"changeRate":-0.030902348578491966,"floatShares":4138000000,"shares":4138000000,"eps":1.314695381885137,"marketStatus":"已收盘","change":-1,"latestTime":"03-30 16:08:20","open":32,"high":32.48,"low":30.94,"amount":1303641149,"amplitude":0.04759,"askPrice":31.4,"askSize":2500,"bidPrice":31.36,"bidSize":55000,"shortable":3,"etf":0,"ttmEps":1.314695381885137,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774920600000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1497283200000,"exchange":"SEHK","adjPreClose":32.36,"openAndCloseTimeList":[[1774834200000,1774843200000],[1774846800000,1774857600000]],"volumeRatio":0.975972,"optionData":{"bulkOrders":[{"symbol":"WXB.HK","call":true,"expireDate":1779897600000,"strike":"50.00","timestamp":1774856802751,"price":0.11,"volume":630,"amount":34650,"type":"*"},{"symbol":"WXB.HK","call":true,"expireDate":1779897600000,"strike":"50.00","timestamp":1774856789237,"price":0.11,"volume":315,"amount":17325,"type":"*"}]},"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXB.HK","impliedVol":0.5495,"impliedVolPercentile":0.565},"requestUrl":"/m/hq/s/02269","defaultTab":"news","newsList":[{"id":"2622811816","title":"大行评级丨招银国际：药明生物增长可见度有所改善，目标价上调至39港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622811816","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622811816?lang=zh_cn&edition=full","pubTime":"2026-03-27 11:17","pubTimestamp":1774581422,"startTime":"0","endTime":"0","summary":"招银国际发表研报指，药明生物去年收入按年增长16.7%，经调整纯利按年增长17.9%，分别较该行预测高出1.2%及9.6%。根据管理层初步指引，预期今年收入增长13%至17%，如撇除外汇波动的潜在影响，料增幅将会更高。该行表示，药明生物的增长可见度有所改善，将其目标价由35.6港元上调至39港元，维持“买入”评级。该行预计公司2026至28年的收入将按年增长14.6%、16.3%及15%，而期内经调整纯利则料升18.7%、17.4%及13.6%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260327/32103737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02269"],"gpt_icon":0},{"id":"1143605090","title":"异动解读 | 大行下调目标价及盈利预测，药明生物盘中大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143605090","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143605090?lang=zh_cn&edition=full","pubTime":"2026-03-26 15:40","pubTimestamp":1774510857,"startTime":"0","endTime":"0","summary":"药明生物今日盘中股价出现大幅下挫，跌幅达5.01%，引起了市场关注。该行同时将公司2026年至2028年的收入预测下调了4%至8%。此外，瑞银也在其研报中下调了药明生物今明两年的每股盈利预测4%至5%，并将目标价由51.6港元微降至49.3港元。尽管瑞银维持“买入”评级，但多家大行相继下调财务预测及目标价，可能引发了投资者的担忧情绪。然而，市场似乎对下调盈利前景的报告反应更为敏感，导致了股价在交易时段的显著下跌。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02269"],"gpt_icon":0},{"id":"2622683988","title":"中金：升药明生物(02269)目标价至48港元 维持“跑赢行业”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2622683988","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622683988?lang=zh_cn&edition=full","pubTime":"2026-03-26 14:36","pubTimestamp":1774506993,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，药明生物(02269)2025年业绩高于该行预期，收入217.9亿元人民币，同比增长16.7%；净利润49.1亿元人民币，同比增长46.3%；经调整净利润56.4亿人民币，同比增长17.9%。考虑到公司经营效率提升，该行上调药明生物2026年及2027年经调整净利润6.3%及9.7%，各至62.1亿及71.9亿人民币，维持“跑赢行业”评级，上调目标价6.7%至48港元。公司业绩超该行预期，盈利能力增强主要因高利润率业务占比提升、产能利用率提高，以及营运效率提升。公司指引2026年收入将实现13-17%同比增长(考虑汇率影响)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02269"],"gpt_icon":0},{"id":"2622076038","title":"药明生物(02269)授出合共2557.5万股受限制股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2622076038","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622076038?lang=zh_cn&edition=full","pubTime":"2026-03-25 20:58","pubTimestamp":1774443499,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明生物(02269)发布公告，于2026年3月25日，其已批准授出合共2557.5万股受限制股份奖励计划受限制股份，但须根据受限制股份奖励计划待承授人接纳，方可作实。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419003.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1610","SG9999002463.SGD","LU0327786744.USD","LU0516423174.USD","LU0516422952.EUR","LU0359201612.USD","LU1794554557.SGD","LU0572944931.SGD","LU0417516738.SGD","LU1242518857.USD","LU1720050803.USD","BK1141","LU3063872942.SGD","LU0359202008.SGD","BK1589","LU0516422366.SGD","LU0051755006.USD","LU0140636845.USD","02269","LU0979878070.USD","LU0708995583.HKD","LU0823426308.USD","LU0856984785.SGD","LU0326950275.SGD","LU0039217434.USD","IE00B0JY6N72.USD","BK1521","LU0823426480.USD","LU0307460666.USD","SG9999002562.SGD","LU0516423091.SGD","LU0456846285.SGD","LU0052750758.USD","LU2039709279.SGD","LU0348825331.USD","LU0819121731.USD","LU0181495838.USD","BK1576","LU0348735423.USD","LU0516422440.USD","LU0456827905.SGD","LU0320764599.SGD","LU0588546209.SGD","LU1242518931.SGD","LU0043850808.USD","LU1880383366.USD","LU0417516902.SGD","LU1688375341.USD"],"gpt_icon":0},{"id":"2622008720","title":"药明生物 2025 年再创新高 数字原生架构驱动卓越运营","url":"https://stock-news.laohu8.com/highlight/detail?id=2622008720","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622008720?lang=zh_cn&edition=full","pubTime":"2026-03-25 18:25","pubTimestamp":1774434300,"startTime":"0","endTime":"0","summary":"上海2026年3月25日 /美通社/ -- 全球领先的合同研究、开发和生产服务公司药明生物正式发布 2025 年年度业绩，公司业绩再创新高，运营能力亦实现显著跃升。引领实验室与工厂智能革命 今年业绩再创新高，数字原生型企业的加速转型成为关键动力。截至2025年12月底，药明生物帮助客户研发和生产的综合项目高达945个，其中包括74个临床III期项目，25个商业化生产项目。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4918943_ZH18943_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU0140636845.USD","BK1521","LU0516423174.USD","LU0516422952.EUR","LU0051755006.USD","BK1610","LU0979878070.USD","LU0327786744.USD","LU1720050803.USD","LU0823426480.USD","SG9999002562.SGD","LU3063872942.SGD","BK1589","LU0456827905.SGD","LU0417516738.SGD","LU0307460666.USD","LU0417516902.SGD","LU0326950275.SGD","SG9999002463.SGD","LU1242518857.USD","LU0052750758.USD","02269","LU0819121731.USD","LU2039709279.SGD","LU0039217434.USD","LU0588546209.SGD","LU0320764599.SGD","BK1141","LU0516423091.SGD","LU0359202008.SGD","LU0572944931.SGD","LU0823426308.USD","IE00B0JY6N72.USD","LU0516422440.USD","LU0348735423.USD","BK1576","LU0708995583.HKD","LU0359201612.USD","LU1242518931.SGD","LU1880383366.USD","LU0516422366.SGD","LU1688375341.USD","LU1794554557.SGD","LU0456846285.SGD","LU0856984785.SGD","LU0348825331.USD","LU0043850808.USD","LU0181495838.USD"],"gpt_icon":0},{"id":"1188427671","title":"药明生物公布2025年创纪录年度业绩，数字化原生架构驱动卓越运营","url":"https://stock-news.laohu8.com/highlight/detail?id=1188427671","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188427671?lang=zh_cn&edition=full","pubTime":"2026-03-25 18:23","pubTimestamp":1774434193,"startTime":"0","endTime":"0","summary":"药明生物（股票代码：02269）宣布其2025年度业绩创下历史新高，公司通过数字化原生架构实现运营效率的显著提升。这一成绩彰显了企业在生物制药领域的领先地位及技术创新能力。\n在数字化战略的推动下，药明生物优化了全流程运营，有效提升了生产效率和客户服务质量。公司凭借先进的技术平台，持续强化在全球市场的竞争力，为长期增长奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","LU0708995583.HKD","LU0516423091.SGD","LU0516422366.SGD","LU0140636845.USD","LU0320764599.SGD","LU0326950275.SGD","LU0327786744.USD","LU0348735423.USD","LU0516422952.EUR","LU0856984785.SGD","SG9999002463.SGD","LU0052750758.USD","LU1720050803.USD","LU1880383366.USD","LU3063872942.SGD","02269","LU0043850808.USD","LU0417516902.SGD","LU0516422440.USD","LU1688375341.USD","LU2039709279.SGD","LU0823426308.USD","LU0456827905.SGD","LU0456846285.SGD","LU0516423174.USD","LU0051755006.USD","LU0307460666.USD","LU0359201612.USD","LU0359202008.SGD","IE00B0JY6N72.USD","LU0572944931.SGD","LU0819121731.USD","LU1794554557.SGD","LU0039217434.USD","LU0823426480.USD","LU0181495838.USD","LU1242518857.USD","LU1242518931.SGD","BK1141","BK1576","BK1589","SG9999002562.SGD","LU0588546209.SGD","BK1610","LU0417516738.SGD","LU0348825331.USD","LU0979878070.USD"],"gpt_icon":0},{"id":"2621061275","title":"大行集体看涨药明生物(02269)，硬核业绩印证长期投资价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2621061275","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621061275?lang=zh_cn&edition=full","pubTime":"2026-03-24 19:41","pubTimestamp":1774352509,"startTime":"0","endTime":"0","summary":"开年以来，药明生物  凭借在摩根大通医疗健康大会披露CRDMO一体化平台内项目突破增长，以及业绩盈喜超预期的财务表现，接连引燃大行两轮“看多潮”。时间上则在集中在药明生物披露2025年业绩盈喜之后。药明生物在2025年实现总收入218亿元，同比增长约16.7%。其研报指出，药明生物2025年业绩预告超出市场及该机构预期。高价值项目管线，将推动药明生物内生增长潜力进一步释放，公司长期投资价值突显。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418196.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0823426480.USD","LU0326950275.SGD","LU0417516738.SGD","LU1720050803.USD","LU0456846285.SGD","LU0516423174.USD","LU0039217434.USD","LU0979878070.USD","LU0320764599.SGD","LU0588546209.SGD","LU1242518857.USD","LU0516422952.EUR","LU3063872942.SGD","LU1242518931.SGD","BK1576","LU1794554557.SGD","LU0417516902.SGD","LU0516422440.USD","LU1880383366.USD","LU0516423091.SGD","LU0051755006.USD","BK1521","LU0856984785.SGD","LU0052750758.USD","LU2039709279.SGD","LU0456827905.SGD","IE00B0JY6N72.USD","LU1688375341.USD","LU0823426308.USD","SG9999002463.SGD","SG9999002562.SGD","BK1141","LU0348825331.USD","BK1610","LU0307460666.USD","LU0181495838.USD","LU0708995583.HKD","LU0516422366.SGD","BK1589","LU0348735423.USD","02269","LU0572944931.SGD","LU0819121731.USD","LU0140636845.USD","LU0043850808.USD","LU0327786744.USD","LU0359201612.USD","LU0359202008.SGD"],"gpt_icon":0},{"id":"1146342837","title":"药明生物2025年调整后净利润56.4亿，同比增长17.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146342837","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146342837?lang=zh_cn&edition=full","pubTime":"2026-03-24 17:46","pubTimestamp":1774345616,"startTime":"0","endTime":"0","summary":"3月24日，$药明生物(02269)$在港公告，2025年，公司收益同比增长16.7%，达人民币217.9亿元。毛利同比增长30.9%至人民币100.19亿元且毛利率同比提升5%至46%。纯利及本公司拥有人应占纯利分别同比增长45.3%及46.3%至人民币57.33亿元及人民币49.08亿元。","market":"sh","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6e9a6fe8ab3f76a85df162b075e8b47f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明生物2025年调整后净利润56.4亿，同比增长17.9%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2328871848.SGD","LU0979878070.USD","LU2045819591.USD","LU1997244956.HKD","LU0039217434.USD","LU1808992512.USD","LU1997245094.SGD","LU2495084118.USD","LU0307460666.USD","LU0572944931.SGD","LU0819121731.USD","LU1979443071.USD","BK1141","LU1720050803.USD","LU0516422366.SGD","LU2039709279.SGD","LU2242644610.SGD","LU1969619763.USD","LU0823426308.USD","SG9999002562.SGD","LU1997245177.USD","LU0348825331.USD","LU0359202008.SGD","LU0856984785.SGD","LU0140636845.USD","LU1046422090.SGD","LU1794554557.SGD","LU0456842615.SGD","LU3063872942.SGD","LU0326950275.SGD","BK0216","IE00B0JY6N72.USD","SG9999002463.SGD","LU0417516902.SGD","LU0516423174.USD","LU1242518857.USD","LU0359201612.USD","LU0516422952.EUR","LU0327786744.USD","LU0181495838.USD","LU0348735423.USD","BK1576","LU0708995583.HKD","LU0516422440.USD","LU0516423091.SGD","LU1242518931.SGD","LU1688375341.USD","02269","LU0588546209.SGD","LU0052750758.USD","LU0051755006.USD","BK1610","LU0417516738.SGD","LU0823426480.USD","LU0456846285.SGD","LU0043850808.USD","LU2125910500.SGD","LU1880383366.USD","BK1583","LU0320764599.SGD","BK1521","LU1934453819.USD","LU0456827905.SGD","BK1589","LU2488822045.USD"],"gpt_icon":0},{"id":"2619408167","title":"每日卖空追踪 | 药明生物 03月13日卖空量成交232.5万股，卖空比例为13.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619408167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619408167?lang=zh_cn&edition=full","pubTime":"2026-03-13 16:30","pubTimestamp":1773390629,"startTime":"0","endTime":"0","summary":"药明生物北京时间03月13日，跌1.71%，卖空量成交232.5万股，较上一交易日减少30.2%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260313163413a6bd1c31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260313163413a6bd1c31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0516422366.SGD","SG9999002463.SGD","LU0456827905.SGD","IE00B0JY6N72.USD","LU0359201612.USD","LU0516423091.SGD","BK1589","LU0819121731.USD","LU0051755006.USD","LU0856984785.SGD","LU0140636845.USD","LU1242518931.SGD","LU0359202008.SGD","LU3063872942.SGD","LU0327786744.USD","LU0708995583.HKD","LU0456846285.SGD","LU1720050803.USD","LU1880383366.USD","BK1521","LU0326950275.SGD","LU0516422952.EUR","LU0572944931.SGD","LU0307460666.USD","LU0043850808.USD","LU0516423174.USD","LU0979878070.USD","LU0348825331.USD","LU0588546209.SGD","02269","LU0320764599.SGD","LU0823426308.USD","BK1141","LU0039217434.USD","LU2039709279.SGD","LU1242518857.USD","BK1610","LU1794554557.SGD","LU0417516738.SGD","LU0181495838.USD","LU0417516902.SGD","SG9999002562.SGD","LU1688375341.USD","LU0516422440.USD","LU0823426480.USD","LU0348735423.USD","BK1576","LU0052750758.USD"],"gpt_icon":0},{"id":"2619650261","title":"港股异动 | 北海康成-B(01228)午后涨超4% 公司完成向药明生物子公司配售股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2619650261","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619650261?lang=zh_cn&edition=full","pubTime":"2026-03-13 14:42","pubTimestamp":1773384153,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，北海康成-B(01228)午后涨超4%，截至发稿，涨4%，报2.6港元，成交额159.38万港元。消息面上，北海康成完成发行合共8403.36万股认购股份。公司此前宣布，向药明生物旗下子公司配售股份。配售完成后，药明生物于北海康成的持股比例将升至约16.27%。公告称，配股事项所得款项净额约1.99亿港元，约12%将用于商业化产品的营运资金及注册维护；28%用于现有产品线的研发开支；60%用于结算集团的贸易应付款项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413524.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0326950275.SGD","LU1242518857.USD","LU0588546209.SGD","01228","LU0456827905.SGD","LU0456846285.SGD","BK1521","LU0348825331.USD","LU0043850808.USD","SG9999002463.SGD","LU0039217434.USD","LU0052750758.USD","LU0140636845.USD","LU0181495838.USD","LU0320764599.SGD","LU0417516738.SGD","VXUS","BK4585","BK1589","LU0823426480.USD","BK1576","LU0359202008.SGD","LU0307460666.USD","LU2039709279.SGD","BK1141","LU1794554557.SGD","LU0359201612.USD","LU0819121731.USD","LU0516423091.SGD","02269","LU0856984785.SGD","LU0348735423.USD","LU0823426308.USD","LU0051755006.USD","LU0417516902.SGD","LU0516423174.USD","LU0979878070.USD","LU1242518931.SGD","LU0516422366.SGD","LU0572944931.SGD","LU1880383366.USD","SG9999002562.SGD","LU0516422440.USD","IE00B0JY6N72.USD","LU0327786744.USD","LU0516422952.EUR","LU1688375341.USD","BK1161","BK1610","LU3063872942.SGD"],"gpt_icon":0},{"id":"2618809931","title":"药明生物与Earendil Labs达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2618809931","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618809931?lang=zh_cn&edition=full","pubTime":"2026-03-12 17:34","pubTimestamp":1773308061,"startTime":"0","endTime":"0","summary":"人民财讯3月12日电，药明生物与生物科技公司EarendilLabs今日共同宣布，双方签署战略合作协议，药明生物将为EarendilLabs管线中多款用于治疗自身免疫性疾病、肿瘤等疾病的双特异性/多特异性抗体及抗体偶联药物（ADC）提供一体化开发与生产服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603123670233769.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02269","LU0708995583.HKD","LU0856984785.SGD","LU1794554557.SGD","LU0456846285.SGD","SG9999002562.SGD","LU1688375341.USD","BK1521","BK1610","LU0516422366.SGD","LU0181495838.USD","LU0348825331.USD","LU0979878070.USD","LU0516423174.USD","LU1242518857.USD","LU0417516902.SGD","BK1576","LU0819121731.USD","LU0320764599.SGD","LU0417516738.SGD","LU0052750758.USD","LU0456827905.SGD","LU0516423091.SGD","LU0823426480.USD","LU1880383366.USD","LU2039709279.SGD","LU0359201612.USD","LU1242518931.SGD","SG9999002463.SGD","LU3063872942.SGD","LU0348735423.USD","LU0572944931.SGD","LU0588546209.SGD","LU0516422440.USD","LU1720050803.USD","LU0039217434.USD","LU0516422952.EUR","LU0307460666.USD","BK1589","LU0823426308.USD","LU0043850808.USD","LU0327786744.USD","LU0051755006.USD","BK1141","IE00B0JY6N72.USD","LU0359202008.SGD","LU0326950275.SGD","LU0140636845.USD"],"gpt_icon":0},{"id":"2618618811","title":"药明生物盘中异动 早盘股价大跌5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618618811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618618811?lang=zh_cn&edition=full","pubTime":"2026-03-09 09:31","pubTimestamp":1773019879,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘09时31分，药明生物股票出现波动，股价急速跳水5.39%。截至发稿，该股报34.380港元/股，成交量241.75万股，换手率0.06%，振幅3.14%。药明生物股票所在的生物技术行业中，整体跌幅为1.93%。其相关个股中，科济药业-B、维立志博-B、派格生物医药-B涨幅较大，振幅较大的相关个股有科济药业-B、药捷安康-B、派格生物医药-B，振幅分别为15.55%、9.51%、8.99%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030909311997aa99aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030909311997aa99aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2039709279.SGD","LU0043850808.USD","LU0708995583.HKD","02269","LU0819121731.USD","LU0516423091.SGD","BK1589","BK1141","LU0516422366.SGD","BK1521","LU0417516902.SGD","LU1720050803.USD","LU0979878070.USD","LU0823426308.USD","LU0326950275.SGD","LU0516423174.USD","LU0307460666.USD","LU1688375341.USD","LU0181495838.USD","LU1242518857.USD","LU0359202008.SGD","LU3063872942.SGD","LU0140636845.USD","BK1576","LU0320764599.SGD","IE00B0JY6N72.USD","LU0516422440.USD","BK1610","LU0051755006.USD","LU0348825331.USD","LU0359201612.USD","LU1880383366.USD","LU0823426480.USD","LU0348735423.USD","LU0856984785.SGD","LU0456827905.SGD","LU0572944931.SGD","SG9999002463.SGD","LU0588546209.SGD","LU0417516738.SGD","LU1242518931.SGD","SG9999002562.SGD","LU0052750758.USD","LU0456846285.SGD","LU0327786744.USD","LU0516422952.EUR","LU1794554557.SGD","LU0039217434.USD"],"gpt_icon":0},{"id":"2617253524","title":"每日卖空追踪 | 药明生物 03月05日卖空量成交486.45万股，卖空比例为14.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617253524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617253524?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:30","pubTimestamp":1772699429,"startTime":"0","endTime":"0","summary":"药明生物北京时间03月05日，涨0.4%，卖空量成交486.45万股，较上一交易日减少53.72%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163348a6a5d8df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163348a6a5d8df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0043850808.USD","LU0588546209.SGD","LU2039709279.SGD","LU1242518857.USD","LU0516423174.USD","LU0979878070.USD","LU0516422952.EUR","BK1576","LU0320764599.SGD","LU0307460666.USD","LU0327786744.USD","LU1720050803.USD","LU0359201612.USD","02269","LU0823426480.USD","LU0516422366.SGD","SG9999002463.SGD","LU0039217434.USD","SG9999002562.SGD","LU0140636845.USD","LU3063872942.SGD","BK1589","BK1610","BK1521","LU0359202008.SGD","LU0456827905.SGD","LU0326950275.SGD","LU0516422440.USD","LU0051755006.USD","LU0456846285.SGD","LU1880383366.USD","LU0516423091.SGD","LU1688375341.USD","LU0417516902.SGD","LU1794554557.SGD","LU0052750758.USD","LU0572944931.SGD","LU0348735423.USD","LU0819121731.USD","LU0823426308.USD","LU0856984785.SGD","BK1141","IE00B0JY6N72.USD","LU0417516738.SGD","LU0348825331.USD","LU1242518931.SGD","LU0181495838.USD","LU0708995583.HKD"],"gpt_icon":0},{"id":"2617524428","title":"药明生物盘中异动 早盘快速上涨3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617524428","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617524428?lang=zh_cn&edition=full","pubTime":"2026-03-05 11:05","pubTimestamp":1772679917,"startTime":"0","endTime":"0","summary":"2026年03月05日早盘11时05分，药明生物股票出现异动，股价急速上涨3.00%。截至发稿，该股报36.360港元/股，成交量1311.9万股，换手率0.32%，振幅1.98%。药明生物股票所在的生物技术行业中，整体涨幅为3.70%。其相关个股中，基石药业-B、药捷安康-B、来凯医药-B涨幅较大，振幅较大的相关个股有药捷安康-B、MIRXES-B、基石药业-B，振幅分别为23.23%、18.66%、11.53%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030511051795431375&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030511051795431375&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0181495838.USD","LU0456846285.SGD","LU1242518931.SGD","LU0348825331.USD","LU2039709279.SGD","BK1589","LU0516422952.EUR","LU0326950275.SGD","LU1688375341.USD","02269","LU0359202008.SGD","LU0823426480.USD","BK1576","LU0708995583.HKD","LU0856984785.SGD","BK1141","BK1610","LU0043850808.USD","LU0979878070.USD","LU0359201612.USD","LU1794554557.SGD","LU1880383366.USD","LU0348735423.USD","LU0516422366.SGD","LU0417516902.SGD","LU0819121731.USD","LU1720050803.USD","SG9999002463.SGD","LU0327786744.USD","LU0140636845.USD","LU0516422440.USD","SG9999002562.SGD","LU0823426308.USD","LU0307460666.USD","LU0588546209.SGD","BK1521","LU0572944931.SGD","LU0052750758.USD","LU0051755006.USD","IE00B0JY6N72.USD","LU1242518857.USD","LU0516423174.USD","LU0516423091.SGD","LU0417516738.SGD","LU0039217434.USD","LU0320764599.SGD","LU0456827905.SGD","LU3063872942.SGD"],"gpt_icon":0},{"id":"1146922512","title":"药明生物（02269）发布2026年2月股份变动月报，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1146922512","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146922512?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:02","pubTimestamp":1772632938,"startTime":"0","endTime":"0","summary":"药明生物（02269）3月4日公布2026年2月股份变动月报。公告显示，截至2026年2月28日，公司注册股本合计6,000,000,000股普通股（面值0.000008333333美元），对应注册股本总额50,000美元，保持与上月末一致。\n公告披露，公司已发行股份数量为4,137,541,236股，报告期内未发生新增发行、回购或注销，也无库存股变动。本月无期权行使，未获得新发行股份，相关激励计划均保持稳定。因此，公司股本结构截至2月底未发生变化。\n根据公告，药明生物确认截至本月末已满足香港联交所主板上市规则的最低公众持股量要求。公告由董事陈智胜签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"gpt_icon":0},{"id":"2616516765","title":"每日卖空追踪 | 药明生物 03月04日卖空量成交486.85万股，卖空比例为9.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616516765","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616516765?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:30","pubTimestamp":1772613028,"startTime":"0","endTime":"0","summary":"药明生物北京时间03月04日，跌4.59%，卖空量成交486.85万股，较上一交易日减少5.9%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163401a6a14ef7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163401a6a14ef7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456827905.SGD","LU1242518931.SGD","LU0043850808.USD","LU0140636845.USD","LU0039217434.USD","LU1880383366.USD","LU0307460666.USD","BK1521","02269","IE00B0JY6N72.USD","LU0823426480.USD","LU1688375341.USD","LU3063872942.SGD","LU0326950275.SGD","LU0456846285.SGD","BK1589","LU0320764599.SGD","SG9999002562.SGD","LU0359202008.SGD","LU0708995583.HKD","LU0516423174.USD","LU0516422440.USD","LU1242518857.USD","LU0516422952.EUR","LU0856984785.SGD","LU0516422366.SGD","BK1141","SG9999002463.SGD","LU0516423091.SGD","LU0359201612.USD","LU0588546209.SGD","LU1720050803.USD","LU0327786744.USD","LU0348825331.USD","LU0979878070.USD","LU0052750758.USD","LU0051755006.USD","LU0348735423.USD","BK1576","LU0417516902.SGD","BK1610","LU2039709279.SGD","LU0181495838.USD","LU0417516738.SGD","LU1794554557.SGD","LU0823426308.USD","LU0819121731.USD","LU0572944931.SGD"],"gpt_icon":0},{"id":"2616366349","title":"药明生物入选标普全球《可持续发展年鉴2026》","url":"https://stock-news.laohu8.com/highlight/detail?id=2616366349","media":"医药健闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616366349?lang=zh_cn&edition=full","pubTime":"2026-03-02 18:41","pubTimestamp":1772448060,"startTime":"0","endTime":"0","summary":"(医药健闻2026年3月02日讯）全球领先的合同研究、开发和生产（CRDMO）服务公司药明生物宣布，凭借2025年在可持续发展领域的卓越表现，公司入选标普全球（S&P Global）《可持续发展年鉴2026》，并在标普全球企业可持续发展评估（CSA）中位列行业前茅，跻身全球前1%。这是药明生物连续四年获此殊荣。该《年鉴》基于标普全球CSA，评选出各行业在可持续发展方面表现优异的企业。在2025年CSA评估的9200家企业中，仅有来自59个行业的848家企业脱颖而出，成功入选该《年鉴》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302184118a7314b15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302184118a7314b15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0181495838.USD","LU0588546209.SGD","LU1688375341.USD","LU0320764599.SGD","LU0359201612.USD","LU1720050803.USD","LU0039217434.USD","IE00B0JY6N72.USD","02269","LU0708995583.HKD","LU0456846285.SGD","LU0819121731.USD","LU0516422952.EUR","LU0823426308.USD","LU1880383366.USD","LU0326950275.SGD","LU0516423174.USD","LU0856984785.SGD","BK1141","LU0456827905.SGD","SG9999002463.SGD","BK1589","LU3063872942.SGD","LU0052750758.USD","LU0348735423.USD","LU0823426480.USD","LU0359202008.SGD","LU0979878070.USD","LU2039709279.SGD","LU0051755006.USD","LU0327786744.USD","LU0516422440.USD","LU0516422366.SGD","SG9999002562.SGD","LU1794554557.SGD","BK1610","LU0307460666.USD","LU0348825331.USD","BK1521","LU0043850808.USD","LU0417516738.SGD","LU0417516902.SGD","LU0516423091.SGD","LU1242518857.USD","LU1242518931.SGD","LU0572944931.SGD","LU0140636845.USD","BK1576"],"gpt_icon":0},{"id":"2616341366","title":"每日卖空追踪 | 药明生物 03月02日卖空量成交286.9万股，卖空比例为7.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616341366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616341366?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:30","pubTimestamp":1772440232,"startTime":"0","endTime":"0","summary":"药明生物北京时间03月02日，跌3.68%，卖空量成交286.9万股，较上一交易日减少54.74%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163417a4415088&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163417a4415088&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0516423174.USD","LU1880383366.USD","02269","LU0417516738.SGD","LU0348825331.USD","LU0979878070.USD","LU0181495838.USD","LU0456846285.SGD","LU1688375341.USD","LU1720050803.USD","LU0856984785.SGD","LU0823426480.USD","LU0823426308.USD","LU0052750758.USD","LU0043850808.USD","LU0708995583.HKD","LU0140636845.USD","LU1794554557.SGD","LU0588546209.SGD","LU0417516902.SGD","LU3063872942.SGD","SG9999002463.SGD","BK1610","LU0819121731.USD","LU0039217434.USD","LU0320764599.SGD","LU0516422366.SGD","LU0456827905.SGD","LU0327786744.USD","LU0307460666.USD","LU0516423091.SGD","LU1242518857.USD","BK1589","LU0326950275.SGD","LU0516422952.EUR","BK1141","BK1576","LU0359201612.USD","LU1242518931.SGD","LU0348735423.USD","BK1521","LU0359202008.SGD","LU0572944931.SGD","SG9999002562.SGD","LU0516422440.USD","LU0051755006.USD","LU2039709279.SGD","IE00B0JY6N72.USD"],"gpt_icon":0},{"id":"2616663463","title":"药明生物03月02日主力大幅流出1.2亿元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2616663463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616663463?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:15","pubTimestamp":1772439359,"startTime":"0","endTime":"0","summary":"03月02日, 药明生物股价跌3.68%，报收38.74元，成交金额14.8亿元，换手率0.93%，振幅4.67%，量比1.32。药明生物今日主力资金净流出1.2亿元，上一交易日主力净流入1586.1万元。该股近5个交易日下跌6.53%，主力资金累计净流出1.3亿元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出4756.6万元，其中净流出天数为10日。该股主力净额占比0.07%，港股市场排名2617/2720。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302162256a4414074&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302162256a4414074&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0140636845.USD","LU0359202008.SGD","LU0417516738.SGD","LU0856984785.SGD","LU3063872942.SGD","BK1589","LU0052750758.USD","LU0039217434.USD","LU0181495838.USD","SG9999002463.SGD","LU0327786744.USD","LU0516422952.EUR","BK1576","SG9999002562.SGD","LU2039709279.SGD","LU0819121731.USD","LU0572944931.SGD","LU0043850808.USD","LU0051755006.USD","LU1720050803.USD","LU0516423091.SGD","LU1688375341.USD","LU0979878070.USD","BK1521","BK1610","LU1794554557.SGD","LU0516422366.SGD","IE00B0JY6N72.USD","LU0456846285.SGD","LU0456827905.SGD","LU0348735423.USD","LU0320764599.SGD","LU0708995583.HKD","LU0307460666.USD","LU0326950275.SGD","LU0588546209.SGD","LU1242518857.USD","BK1141","02269","LU0359201612.USD","LU0417516902.SGD","LU0516422440.USD","LU0823426480.USD","LU1880383366.USD","LU1242518931.SGD","LU0348825331.USD","LU0516423174.USD","LU0823426308.USD"],"gpt_icon":0},{"id":"2616826552","title":"医药行业周报：哮喘与COPD：长效化、生物药加速突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2616826552","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616826552?lang=zh_cn&edition=full","pubTime":"2026-03-01 00:00","pubTimestamp":1772294400,"startTime":"0","endTime":"0","summary":"核心观点：哮喘与COPD的异质性决定了2型炎症通路的精准分层与生物标志物驱动的个体化治疗是生物制剂价值兑现的前提；行业呈现“单靶点长效化”与“多靶点协同”的技术迭代趋势，同时COPD异质性催生出PDE3/4吸入制剂与生物制剂并行的双主线格局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260301134212a43d2b3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260301134212a43d2b3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","06978","BK1161","02359","BK1141","03347","BK1583","BK1574","02269"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxibiologics.com","stockEarnings":[{"period":"1week","weight":-0.0432},{"period":"1month","weight":-0.2176},{"period":"3month","weight":-0.0074},{"period":"6month","weight":-0.1715},{"period":"1year","weight":0.1661},{"period":"ytd","weight":0.0293}],"compareEarnings":[{"period":"1week","weight":-0.0129},{"period":"1month","weight":-0.0678},{"period":"3month","weight":-0.0336},{"period":"6month","weight":-0.045},{"period":"1year","weight":0.0582},{"period":"ytd","weight":-0.0265}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明生物技术有限公司是一家主要从事向生物制剂行业的客户提供就生物发现、开发及生产的端到端解决方案及服务的投资控股公司。该公司主要通过两个分部运营其业务。生物药分部主要从事提供生物药的发现、开发和生产。药明合联（XDC）分部主要从事为抗体偶联药物（ADCs）及各种生物偶联药物提供合同研究、开发及生产组织（CRDMO）服务。该公司主要在国内和国外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.777778,"avgChangeRate":0.052868},{"month":2,"riseRate":0.555556,"avgChangeRate":0.006907},{"month":3,"riseRate":0.555556,"avgChangeRate":-0.0038},{"month":4,"riseRate":0.375,"avgChangeRate":-0.000625},{"month":5,"riseRate":0.5,"avgChangeRate":0.00166},{"month":6,"riseRate":0.625,"avgChangeRate":0.064583},{"month":7,"riseRate":0.666667,"avgChangeRate":0.081469},{"month":8,"riseRate":0.555556,"avgChangeRate":0.030253},{"month":9,"riseRate":0.666667,"avgChangeRate":0.056337},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.033632},{"month":11,"riseRate":0.444444,"avgChangeRate":0.025584},{"month":12,"riseRate":0.555556,"avgChangeRate":0.009161}],"exchange":"SEHK","name":"药明生物","nameEN":"WUXI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明生物,02269,药明生物股票,药明生物股票老虎,药明生物股票老虎国际,药明生物行情,药明生物股票行情,药明生物股价,药明生物股市,药明生物股票价格,药明生物股票交易,药明生物股票购买,药明生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}